Literature DB >> 487692

Phenytoin cumulation kinetics.

J P Allen, T M Ludden, S R Burrow, W A Clementi, S A Stavchansky.   

Abstract

Four male subjects were given phenytoin orally in single or twice-daily doses. Subjects were on 2 or 3 different dosing rates from 260 to 600 mg phenytoin sodium daily. Predose blood samples were obtained almost daily. The resulting serum levels, measured by gas-liquid chromatography, ranged from 1 to 18 micrograms/ml. Serum phenytoin concentration-time data were fit to a 1-compartment open model with zero-order input and Michaelis-Menten elimination. The resulting computer-generated parameter estimates (Vmax, 5.28 to 8.41 mg/kg/day; Km, 0.83 to 4.18 mg/1; Vd, 0.74 to 0.97 1/kg) are in agreement with the ranges of values in the literature. The time course of phenytoin cumulation is compatible with the presence of a major elimination pathway exhibiting Michaelis-Menten kinetic behavior.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 487692     DOI: 10.1002/cpt1979264445

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  7 in total

Review 1.  Therapeutic drug monitoring of phenytoin. Rationale and current status.

Authors:  M Levine; T Chang
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

2.  Applying organ clearance concepts in a clinical setting.

Authors:  Jorge Duconge
Journal:  Am J Pharm Educ       Date:  2008-10-15       Impact factor: 2.047

Review 3.  Anticonvulsant drugs. An update.

Authors:  M J Eadie
Journal:  Drugs       Date:  1984-04       Impact factor: 9.546

4.  Rapid and slow release phenytoin in epileptic patients at steady state: assessment of relative bioavailability utilizing Michaelis-Menten parameters.

Authors:  R J Sawchuk; S M Pepin; I E Leppik; R J Gumnit
Journal:  J Pharmacokinet Biopharm       Date:  1982-08

Review 5.  Phenytoin versus Leviteracetam for seizure prophylaxis after brain injury - a meta analysis.

Authors:  Syed Nabeel Zafar; Abdul Ahad Khan; Asfar Ayaz Ghauri; Muhammad Shahzad Shamim
Journal:  BMC Neurol       Date:  2012-05-29       Impact factor: 2.474

6.  Cost-effectiveness analysis of intravenous levetiracetam versus intravenous phenytoin for early onset seizure prophylaxis after neurosurgery and traumatic brain injury.

Authors:  Rashid Kazerooni; Mark Bounthavong
Journal:  Clinicoecon Outcomes Res       Date:  2010-03-05

7.  Evaluation framework for systems models.

Authors:  Sietse Braakman; Pras Pathmanathan; Helen Moore
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2022-01-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.